Sponsor Pipeline

Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06927466 A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019… Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Recruiting
NCT06970496 A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell… Relapsed or Refractory B Cell Non Hodgkin Lymphoma Not Yet Recruiting
Disease Areas
Leukemia (1) Acute Lymphoblastic Leukemia (ALL) (1) Non-Hodgkin Lymphoma (1)
Get alerts when Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free